PEN icon

Penumbra

338.80 USD
+0.80
0.24%
At close Updated Mar 18, 1:51 PM EDT
1 day
0.24%
5 days
1.03%
1 month
-0.74%
3 months
7.44%
6 months
31.45%
Year to date
9.5%
1 year
23.07%
5 years
21.87%
10 years
619.93%
 

About: Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.

Employees: 4,700

0
Funds holding %
of 8,085 funds
0
Analysts bullish %
of 12 analysts
0
Positive news %
of 7 articles
Price charts implemented using Lightweight Charts™